Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Grant US-11732030-B2 United States of America 22 Aug 2023
NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST SARBECOVIRUSES Application WO-2023073441-A1 World Intellectual Property Organisation (WIPO) 04 May 2023
NOVEL MONOCLONAL ANTIBODIES AGAINST SARS-CoV-2 AND USES THEREOF N/A TW-I799855-B Chinese Taipei 21 Apr 2023
Antibody for resisting novel coronavirus and application thereof Application CN-115975019-A China 18 Apr 2023
Antibody for resisting novel coronavirus and application thereof Application CN-115960218-A China 14 Apr 2023
METHODS AND KIT FOR DETERMINING THE ANTIBODY STATUS AND T-CELL IMMUNITY AGAINST SARS-COV-2 Application WO-2023031437-A1 World Intellectual Property Organisation (WIPO) 09 Mar 2023
METHODS AND KIT FOR DETERMINING THE ANTIBODY STATUS AND T-CELL IMMUNITY AGAINST SARS-COV-2 Application EP-4145132-A1 European Patent Office 08 Mar 2023
Viral vaccine vector for immunization against betacoronavirus Application KR-20230016193-A Republic of Korea 01 Feb 2023
ANTIBODY BINDING TO RBD OF THE SPIKE PROTEIN OF SARS-COV-2 AND A METHOD FOR QUANTIFYING… Application WO-2022237924-A1 World Intellectual Property Organisation (WIPO) 17 Nov 2022
ANTIBODY BINDING TO RBD OF SPIKE PROTEIN OF SARS-COV-2 AND A METHOD FOR QUANTIFYING… Application EP-4089112-A1 European Patent Office 16 Nov 2022
EXPRESSION VECTOR FOR ANTI-SARS-COV-2 NEUTRALIZING ANTIBODIES Application WO-2022156653-A1 World Intellectual Property Organisation (WIPO) 28 Jul 2022
Anti-SARS-COV-2 antibodies and uses thereof Grant US-11365239-B2 United States of America 21 Jun 2022
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS INFECTION, INCLUDING SARS-COV-2 Application WO-2022120366-A1 World Intellectual Property Organisation (WIPO) 09 Jun 2022
INTRANASAL ANTIVIRAL THERAPY FOR MUCOSAL PROTECTION AGAINST VIRUS INFECTIONS Application WO-2022098525-A1 World Intellectual Property Organisation (WIPO) 12 May 2022
SARS-COV2 ANTIBODIES Application WO-2022058618-A3 World Intellectual Property Organisation (WIPO) 28 Apr 2022
ANTIBODY SPECIFIC FOR SARS-COV-2 RECEPTOR BINDING DOMAIN AND THERAPEUTIC METHODS Application WO-2022081436-A1 World Intellectual Property Organisation (WIPO) 21 Apr 2022
ANTIBODY AGAINST CORONAVIRUS Application WO-2022059801-A1 World Intellectual Property Organisation (WIPO) 24 Mar 2022
ANTIBODY AGAINST SARS-COV-2 CORONAVIRUS S PROTEIN AND APPLICATION THEREOF Application WO-2022041745-A1 World Intellectual Property Organisation (WIPO) 03 Mar 2022
ANTI-SARS-COV-2 ANTIBODIES Application WO-2022035918-A1 World Intellectual Property Organisation (WIPO) 17 Feb 2022
COVID-19 MUCOSAL ANTIBODY ASSAY Application WO-2022018528-A1 World Intellectual Property Organisation (WIPO) 27 Jan 2022
LATERAL FLOW ASSAY DEVICE FOR DETECTION OF ANALYTES AND METHOD OF DETECTION THEREOF Application WO-2021255755-A1 World Intellectual Property Organisation (WIPO) 23 Dec 2021
METHODS AND COMPOSITIONS RELATED TO NEUTRALIZING ANTIBODIES AGAINST HUMAN CORONAVIRUS Application WO-2021254403-A1 World Intellectual Property Organisation (WIPO) 23 Dec 2021
ANTI-SARS-COV-2 SPIKE PROTEIN ANTIBODIES AND METHODS OF USE Application WO-2021226179-A3 World Intellectual Property Organisation (WIPO) 16 Dec 2021
ANTI-CORONAVIRUS ANTIBODIES AND USES THEREOF Application WO-2021249547-A1 World Intellectual Property Organisation (WIPO) 16 Dec 2021
ANTI-SAR-COV-2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF Application WO-2021248276-A1 World Intellectual Property Organisation (WIPO) 16 Dec 2021
HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2) Application WO-2021245184-A1 World Intellectual Property Organisation (WIPO) 09 Dec 2021
NEUTRALIZING ANTIBODIES AGAINST SARS-RELATED CORONAVIRUS Application WO-2021239935-A1 World Intellectual Property Organisation (WIPO) 02 Dec 2021
ANTI-SARS-COV-2 SPIKE PROTEIN MONOCLONAL ANTIBODY Application WO-2021233433-A1 World Intellectual Property Organisation (WIPO) 25 Nov 2021
POLYPEPTIDES ENCODING ANTIBODIES BINDING TO SARS-COV-2 SPIKE PROTEIN Application WO-2021234392-A1 World Intellectual Property Organisation (WIPO) 25 Nov 2021
MONOCLONAL ANTIBODY FOR NOVEL CORONAVIRUS, OR ANTIGEN BINDING PART THEREOF Application WO-2021227138-A1 World Intellectual Property Organisation (WIPO) 18 Nov 2021
NEUTRALIZING ANTIBODIES BINDING TO THE SPIKE PROTEIN OF SARS-COV-2 SUITABLE FOR USE IN… Application WO-2021228904-A1 World Intellectual Property Organisation (WIPO) 18 Nov 2021
ANTI-SARS-COV-2 ANTIBODIES Application WO-2021229561-A1 World Intellectual Property Organisation (WIPO) 18 Nov 2021
INHIBITION OF SARS-COV-2 INFECTION THROUGH SYNDECANS Application WO-2021229249-A1 World Intellectual Property Organisation (WIPO) 18 Nov 2021
COVID-19 ANTIBODIES AND USES THEREOF Application WO-2021226405-A1 World Intellectual Property Organisation (WIPO) 11 Nov 2021
NOVEL ANKYRIN REPEAT BINDING PROTEINS AND THEIR USES Application WO-2021224686-A1 World Intellectual Property Organisation (WIPO) 11 Nov 2021
ANTIBODIES AGAINST SARS-COV-2 Application WO-2021226560-A1 World Intellectual Property Organisation (WIPO) 11 Nov 2021
ANTI-SARS-COV-2 MONOCLONAL ANTIBODY COMPOSITIONS Application WO-2021221668-A1 World Intellectual Property Organisation (WIPO) 04 Nov 2021
ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME Application WO-2021211775-A1 World Intellectual Property Organisation (WIPO) 21 Oct 2021
ANTIGEN-BINDING PROTEIN TO SARS-CoV-2 Application WO-2021206636-A1 World Intellectual Property Organisation (WIPO) 14 Oct 2021
IMMUNOTHERAPY TARGETING A CONSERVED REGION IN SARS CORONAVIRUSES Application WO-2021203053-A1 World Intellectual Property Organisation (WIPO) 07 Oct 2021
ANTIBODY HAVING NEUTRALIZING ACTIVITY AGAINST CORONAVIRUS, AND USE THEREOF Application WO-2021196268-A1 World Intellectual Property Organisation (WIPO) 07 Oct 2021
SARS-COV-2 (SARS2, COVID-19) ANTIBODIES Application WO-2021180602-A1 World Intellectual Property Organisation (WIPO) 16 Sep 2021
SARS-COV-2 (SARS2, COVID-19) ANTIBODIES Application WO-2021180604-A1 World Intellectual Property Organisation (WIPO) 16 Sep 2021
ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME Application WO-2021158521-A1 World Intellectual Property Organisation (WIPO) 12 Aug 2021
Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments Grant US-10975139-B1 United States of America 13 Apr 2021
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Grant US-10954289-B1 United States of America 23 Mar 2021
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Grant US-10787501-B1 United States of America 29 Sep 2020